Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
AMEOVA
- Development stage
- Unknown
- Lead developer
- Adorshea Bioceutics
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
AMEOVA is a combination nutraceutical product developed by Adorshea Bioceutics, specifically formulated for the management of poor ovarian reserve (POR) and female infertility. The product typically contains a synergistic blend of dehydroepiandrosterone (DHEA) in a sustained-release formulation, Coenzyme Q10 (ubiquinone), and melatonin. DHEA serves as a pro-hormone precursor for follicular steroidogenesis, which is thought to improve the follicular microenvironment and increase the number of recruitable follicles in women with diminished ovarian reserve. Coenzyme Q10 acts as an essential electron carrier in the mitochondrial respiratory chain, providing antioxidant protection and supporting oocyte bioenergetics. Melatonin further contributes to the antioxidant defense system within the pre-ovulatory follicle, protecting oocytes from oxidative stress-induced damage. AMEOVA is approved and marketed in India as a therapeutic supplement to improve pregnancy outcomes in assisted reproductive technology (ART) cycles.
- Brand names
- AMEOVA
- Other names
- AMEOVA
02
Targets
MTNR1A (MT1)AR (Adrenergic receptors)
Beyond the preview
Go deeper on AMEOVA.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on AMEOVA.